%0 Generic
%T CetuGEX and cetuximab in recurrent/metastatic squamous cell carcinoma of the head and neck (RM-HNSCC): PK/PD results from the phase II RESGEX study.
%A Baumeister, Hans
%A Zurlo, Alfredo
%A Fayette, Jerome
%A Dietrich, Bruno
%A Keilholz, Ulrich
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%D 2018
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation